Literature DB >> 16831472

Complications of tracheotomy in patients with mucopolysaccharidoses type II (Hunter syndrome).

Han-Sin Jeong1, Do-Yeon Cho, Kang Mo Ahn, Dong-Kyu Jin.   

Abstract

OBJECTIVE: To investigate the complication rate of tracheotomy in patients with mucopolysacchridoses (MPS) type II (Hunter syndrome).
MATERIALS AND METHODS: From 2004 to 2005, seven tracheotomy procedures were performed for the airway management in three patients with MPS type II. The complications for each procedure were analyzed, which included the stomal narrowing, granulation formation, infrastomal tracheal stenosis, and wound infection.
RESULTS: All tracheotomies in patients with MPS type II resulted in tracheotomy-related complications, though these procedures secured a safe airway. Infrastomal tracheal stenosis was the most frequent complication (85.7%) and stomal narrowing also occurred frequently (71.4%) after each tracheotomy. These complications caused cannula care to be difficult, with revision frequently required.
CONCLUSION: Of the complications observed after tracheotomy, infrastomal tracheal stenosis and stomal narrowing are frequent in patients with MPS type II. Therefore, tracheotomy procedures should be cautiously applied to the MPS type II patients, and the complications associated with tracheotomy should be discussed with caregivers preoperatively.

Entities:  

Mesh:

Year:  2006        PMID: 16831472     DOI: 10.1016/j.ijporl.2006.05.021

Source DB:  PubMed          Journal:  Int J Pediatr Otorhinolaryngol        ISSN: 0165-5876            Impact factor:   1.675


  7 in total

1.  Management of Life-Threatening Tracheal Stenosis and Tracheomalacia in Patients with Mucopolysaccharidoses.

Authors:  Christoph Kampmann; Christiane M Wiethoff; Ralf G Huth; Gundula Staatz; Eugen Mengel; Michael Beck; Stefan Gehring; Torsten Mewes; Tariq Abu-Tair
Journal:  JIMD Rep       Date:  2016-07-22

2.  Mucopolysaccharidosis type II: European recommendations for the diagnosis and multidisciplinary management of a rare disease.

Authors:  Maurizio Scarpa; Zsuzsanna Almássy; Michael Beck; Olaf Bodamer; Iain A Bruce; Linda De Meirleir; Nathalie Guffon; Encarna Guillén-Navarro; Pauline Hensman; Simon Jones; Wolfgang Kamin; Christoph Kampmann; Christina Lampe; Christine A Lavery; Elisa Leão Teles; Bianca Link; Allan M Lund; Gunilla Malm; Susanne Pitz; Michael Rothera; Catherine Stewart; Anna Tylki-Szymańska; Ans van der Ploeg; Robert Walker; Jiri Zeman; James E Wraith
Journal:  Orphanet J Rare Dis       Date:  2011-11-07       Impact factor: 4.123

Review 3.  ENT and mucopolysaccharidoses.

Authors:  Pier Marco Bianchi; Renato Gaini; Silvano Vitale
Journal:  Ital J Pediatr       Date:  2018-11-16       Impact factor: 2.638

Review 4.  Anaesthesia and airway management in mucopolysaccharidosis.

Authors:  Robert Walker; Kumar G Belani; Elizabeth A Braunlin; Iain A Bruce; Henrik Hack; Paul R Harmatz; Simon Jones; Richard Rowe; Guirish A Solanki; Barbara Valdemarsson
Journal:  J Inherit Metab Dis       Date:  2012-11-30       Impact factor: 4.982

Review 5.  Respiratory and sleep disorders in mucopolysaccharidosis.

Authors:  Kenneth I Berger; Simone C Fagondes; Roberto Giugliani; Karen A Hardy; Kuo Sheng Lee; Ciarán McArdle; Maurizio Scarpa; Martin J Tobin; Susan A Ward; David M Rapoport
Journal:  J Inherit Metab Dis       Date:  2012-11-15       Impact factor: 4.982

6.  Hunter Syndrome Diagnosed by Otorhinolaryngologist.

Authors:  Ayako Hashimoto; Tadayuki Kumagai; Hiroyuki Mineta
Journal:  Case Rep Otolaryngol       Date:  2018-05-13

7.  Mediastinal Tracheostoma for Treatment of Tracheostenosis after Tracheostomy in a Patient with Mucopolysaccharidosis-Induced Tracheomalacia.

Authors:  Yasuhiro Chikaishi; Kenichi Kobayashi; Shuichi Shinohara; Akihiro Taira; Yusuke Nabe; Shinji Shinohara; Taiji Kuwata; Masaru Takenaka; Soichi Oka; Ayako Hirai; Kazue Yoneda; Koji Kuroda; Naoko Imanishi; Yoshinobu Ichiki; Fumihiro Tanaka
Journal:  Case Rep Surg       Date:  2017-10-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.